Skip to main content
DBD
NYSE Technology

10% Owner Sells $34 Million in Diebold Nixdorf Stock

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Negative
Importance info
7
Price
$68.61
Mkt Cap
$2.461B
52W Low
$34.875
52W High
$72.295
52W Position info
97% above low
Off High info
5.1% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

DBD sits 97% above its 52-week low of $34.875.

Summary

Millstreet Capital Management LLC, a 10% owner of Diebold Nixdorf, along with its managing members, reported an open market sale of $34 million worth of common stock. This significant disposition represents a notable reduction in their holdings.


Key Events · Ownership and Investor Activity · DBD

  • Significant Share Sale

    Millstreet Capital Management LLC, a 10% owner, disposed of 500,000 shares of common stock in an open market transaction.

  • Substantial Value

    The shares were sold for a total value of $34,000,000 at a price of $68.00 per share on January 15, 2026.

  • Post-Transaction Holdings

    Following the sale, the reporting owners collectively hold 5,216,672 shares of Diebold Nixdorf common stock.


Analysis · DBD · Technology

The sale of $34 million in Diebold Nixdorf common stock by a 10% owner, Millstreet Capital Management LLC, and its managing members, is a significant transaction. While institutional investors often sell for portfolio rebalancing or liquidity, a disposition of this magnitude by a major shareholder can be interpreted as a reduction in conviction or a strategic shift. Investors should monitor future filings for further changes in ownership by this group.

How filings like this one have moved

In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, DBD was trading at $68.61 on NYSE in the Technology sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $34.88 to $72.30. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DBD - Latest Insights

DBD
Jul 31, 2026, 4:27 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $73.93
Real-time Price: $61.22 info
Change: -$12.71 (-17%) info
Market Cap: $2.078B info
DBD
Jul 29, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $75.17
Real-time Price: $61.22 info
Change: -$13.95 (-19%) info
Market Cap: $2.078B info
DBD
Jul 29, 2026, 7:06 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $90.75
Real-time Price: $61.22 info
Change: -$29.53 (-33%) info
Market Cap: $2.078B info
DBD
Jun 26, 2026, 4:01 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $84.98
Real-time Price: $61.22 info
Change: -$23.76 (-28%) info
Market Cap: $2.078B info
DBD
Apr 30, 2026, 7:06 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $82.50
Real-time Price: $61.22 info
Change: -$21.28 (-26%) info
Market Cap: $2.078B info